Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

書誌詳細
第一著者:	Flora, Sanzida Alam
その他の著者:	Azam, Faruque
フォーマット:	学位論文
言語:	English
出版事項:	Brac University 2024
主題:	NSCLC Tyrosine kinase inhibitor Efficacy endpoints Cancer therapy Lung cancer Lung cancer > Treatment Protein-tyrosine kinase > Inhibitors > Therapeutic use
オンライン･アクセス:	http://hdl.handle.net/10361/23693

類似資料

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
著者:: Khan, Muidul Hasan
出版事項: (2024)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
著者:: Paul, Pulock
出版事項: (2024)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
著者:: Rahman, Tasnim
出版事項: (2024)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
著者:: Sorno, Rubina Haque
出版事項: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
著者:: Hoque, Ismoth Ara
出版事項: (2024)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
著者:: Karim, Samia Binte
出版事項: (2024)

Immunotherapy in the Management of Lung Cancer
著者:: Tasnim, Humayra
出版事項: (2022)

Molecules associated with the development of lung cancer
著者:: Rahman, Adree, 等
出版事項: (2023)

Protein biomarkers for Lung Cancer: a bioinformatic approach
著者:: Jeba, Joynob
出版事項: (2017)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
著者:: Meem, Manila
出版事項: (2023)

A review on targeted therapies for lung cancer
著者:: Ashraf, Anushey
出版事項: (2023)

Potential of liposomes for the treatment of lung cancer- a review
著者:: Mim, Shanzida
出版事項: (2023)

A review on recent advances in drugs for lung cancer treatment
著者:: Noor, Fouzia
出版事項: (2024)

A review on potential of PARP inhibitors in the treatment of prostate cancer
著者:: Islam, Saidul
出版事項: (2022)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
著者:: Das, Reshita
出版事項: (2024)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
著者:: Pial, Sazia Afrin
出版事項: (2018)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
著者:: Razna, Amrin Islam
出版事項: (2019)

Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
著者:: Shobnam, Sohana
出版事項: (2024)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
著者:: Shabnam, Musharrat
出版事項: (2018)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
著者:: Zangmo, Thinley
出版事項: (2024)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
著者:: Tania, Umme
出版事項: (2023)

In silico modelling and structural dynamics of PSY1R kinase domain and its interaction with SERK1 kinase
著者:: Ruhee, Noshin Nawer
出版事項: (2022)

RIPK pathway, as a potential target, for cancer treatment - a review
著者:: Jahan, Nusrat
出版事項: (2024)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
著者:: Bristy, Israt Zerin
出版事項: (2021)

Lung cancer detection and classification using machine learning
著者:: Arefin, Mahbubul, 等
出版事項: (2023)

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
著者:: Karim, Azrin
出版事項: (2024)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
著者:: Haque, Mushfiqul
出版事項: (2019)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
著者:: Mukti, Roushney Fatima, 等
出版事項: (2016)

A review on insulin-producing beta cell: regenerative role of drugs acting on DYRK1A, GLP-1 and DPP-4 receptors
著者:: Mahmood, Nyrit
出版事項: (2021)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
著者:: Ratu, Tabassum
出版事項: (2024)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
著者:: Mirza, Maisa Tasnim
出版事項: (2023)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
著者:: Nandy, Aditi
出版事項: (2022)

Statistics and informatics in molecular cancer research

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
著者:: Hasan, Amit
出版事項: (2024)

Identification of FAP inhibitors using in silico simulation study
著者:: Deeba, Maliha Tasnim
出版事項: (2018)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
著者:: Abir, Shifaty Nur
出版事項: (2024)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
著者:: Hossain, Safa Binte
出版事項: (2019)

Recent advances in Cancer treatment targeting autophagy and future aspects
著者:: Emon, Kamrul Hasan
出版事項: (2022)

Cancer risk factors: a critical review
著者:: Tabassum, Tahsina
出版事項: (2017)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
著者:: Nawar, Anika
出版事項: (2019)